| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/09/2009 | US20090176217 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 07/09/2009 | US20090176211 Fluorescent protein |
| 07/09/2009 | US20090176209 Selection |
| 07/09/2009 | US20090176205 Mutant proteins in the dna-binding domain of a telomeric protein, trf2, and telomeric dna mutants, and use of the complex structure of the trf2 dna-binding domain and telomeric dna |
| 07/09/2009 | US20090175983 Gene capable of improving low temperature fermentability and/or low temperature resistance and use thererof |
| 07/09/2009 | US20090175981 Compositions, methods and uses for a novel family of peptides |
| 07/09/2009 | US20090175974 NOVEL CADHERIN RECEPTOR PEPTIDE FOR POTENTIATING Bt BIOPESTICIDES |
| 07/09/2009 | US20090175912 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system |
| 07/09/2009 | US20090175910 Modifications of HIV Env, Gag, and Pol enhance immunogenicity for genetic immunization |
| 07/09/2009 | US20090175909 Influenza Hemagglutinin And Neuraminidase Variants |
| 07/09/2009 | US20090175908 Influenza Hemagglutinin And Neuraminidase Variants |
| 07/09/2009 | US20090175907 Multi Plasmid System For The Production Of Influenza Virus |
| 07/09/2009 | US20090175899 Recombinant rsv virus expression systems and vaccines |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | US20090175889 Hiv vaccine |
| 07/09/2009 | US20090175876 Methods of using phhla2 to co-stimulate t-cells |
| 07/09/2009 | US20090175874 Novel interleukin-1 receptor intracellular ligand proteins and inhibitors of ligand binding |
| 07/09/2009 | US20090175855 Novel compositions and methods for the treatment of immune related diseases |
| 07/09/2009 | US20090175850 NOGO Receptor Homologs |
| 07/09/2009 | US20090175844 Method of diagnosing bladder cancer |
| 07/09/2009 | US20090175830 Oncolytic adenovirus armed with therapeutic genes |
| 07/09/2009 | US20090175828 Coagulation Factor X Polypeptides With Modified Activation Properties |
| 07/09/2009 | US20090175819 Molecule and chimeric molecules thereof |
| 07/09/2009 | US20090175789 Antibody raised against the ldl receptor |
| 07/09/2009 | DE102008003028A1 Producing proteins with defined structures and functional properties in biological systems comprises controlled alternative splicing of gene sequences |
| 07/09/2009 | CA2710952A1 Compositions and methods for treating erectile dysfunction |
| 07/09/2009 | CA2710760A1 Cynomolgus toll-like receptor 3 |
| 07/09/2009 | CA2710356A1 Methods for packaging propagation-defective vesicular stomatitis virus vectors |
| 07/09/2009 | CA2710166A1 Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein |
| 07/09/2009 | CA2709890A1 Cell culture processes |
| 07/09/2009 | CA2709697A1 Novel protein |
| 07/09/2009 | CA2709517A1 Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants |
| 07/09/2009 | CA2709485A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 07/09/2009 | CA2709371A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 07/09/2009 | CA2709367A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 07/09/2009 | CA2708549A1 Bmp mutants with decreased susceptibility to noggin |
| 07/09/2009 | CA2705925A1 Yeast strains for protein production |
| 07/09/2009 | CA2704283A1 Vaccine |
| 07/08/2009 | EP2077328A1 Platelet aggregation inhibitor composition |
| 07/08/2009 | EP2077279A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 07/08/2009 | EP2077278A1 Peptide derived from neurotensin receptor 3 and use in the treatment of psychiatric disorders |
| 07/08/2009 | EP2077277A1 Use of mammalian cytokine; related reagents |
| 07/08/2009 | EP2077276A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogensis |
| 07/08/2009 | EP2077275A2 IgA nephropathy-related DNA |
| 07/08/2009 | EP2077274A1 Synthetic analogs of human beta-defensins having antimicrobial, antiviral and chemotactic activity |
| 07/08/2009 | EP2077273A1 Methods for separating casein from soluble proteins in a composition |
| 07/08/2009 | EP2076777A2 Method for detecting il-16 activity and modulation of il-16 activity based on phosphorylated stat-6 proxy levels |
| 07/08/2009 | EP2076603A2 A serum-free virus propagation platform for a virus vaccine candidate |
| 07/08/2009 | EP2076596A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/08/2009 | EP2076537A2 Prevention of tissue ischemia, related methods and compositions |
| 07/08/2009 | EP2076536A2 Variants of ctla4 |
| 07/08/2009 | EP2076535A2 Receptor(sstr2)-selective somatostatin antagonists |
| 07/08/2009 | EP2076534A1 Peptides with high affinity for the prolactin receptor |
| 07/08/2009 | EP2076533A2 Modified interferon beta polypeptides and their uses |
| 07/08/2009 | EP2076532A2 Cytokine derivatives |
| 07/08/2009 | EP2076531A1 Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof |
| 07/08/2009 | EP2076530A1 Avian derived erythropoietin |
| 07/08/2009 | EP2076529A1 Antibacterial and antiviral peptides from actinomadura namibiensis |
| 07/08/2009 | EP2076291A2 Codon optimized cftr |
| 07/08/2009 | EP2076283A2 Methods of disrupting quorum sensing to affect microbial population cell density |
| 07/08/2009 | EP2076279A2 Native (telopeptide) placental collagen compositions |
| 07/08/2009 | EP2076276A2 Sol-gel materials for cellular modulation |
| 07/08/2009 | EP2076272A2 Generating an immune response by inducing cd40 and pattern recognition receptors |
| 07/08/2009 | EP2076140A1 Product, suitable to be given to the human body for its protective effects and health benefits, based on cow buffalo's milk self-enriched with lactoferrin, or pure lactoferrin, obtained through membrane separative processes |
| 07/08/2009 | EP1778268A4 Treatment of renal dysfunction and multiple myeloma using pacap compounds |
| 07/08/2009 | EP1750743A4 Oral formulations comprising bone morphogenetic proteins for treating metabolic bone diseases |
| 07/08/2009 | EP1682074A4 Compositions and methods for healthy pregnancy |
| 07/08/2009 | EP1670413A4 Method of reducing visceral fat by increasing levels of insulin-like growth factor-i (igf-i) |
| 07/08/2009 | EP1627063B1 Flowering induction |
| 07/08/2009 | EP1558287A4 Uses of human zven antagonists |
| 07/08/2009 | EP1536808B1 Heterocarpin, a plant-derived protein with anti-cancer properties |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1371730B1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/08/2009 | EP1313871B1 NUCLEOTIDE SEQUENCES WHICH CODE FOR THE metY GENE |
| 07/08/2009 | EP1281759B1 Method of inhibiting the formation of by-product in the production of genetically modified polypeptide |
| 07/08/2009 | EP1232175B1 Method of forming a peptide-receptor complex with zsig33 polypeptides. |
| 07/08/2009 | CN101479295A Methods and compositions relating to ZPA polypeptides |
| 07/08/2009 | CN101479294A Isolated polynucleotide molecules corresponding to mutant and wild-type alleles of the maize D9 gene and methods of use |
| 07/08/2009 | CN101479293A Polypeptides from neisseria meningitidis |
| 07/08/2009 | CN101475638A Method for extracting sturgeon skin collagen |
| 07/08/2009 | CN101475637A Preparation of carbaryl and methyl parathion universal antibody and universal envelope antigen |
| 07/08/2009 | CN101475636A Human interferon-like protein and use thereof |
| 07/08/2009 | CN101475635A Recombinant porcine interferon-alpha, as well as preparation method and use thereof |
| 07/08/2009 | CN101475634A Extracting method for plant chloroplast total protein and special extract therefor |
| 07/08/2009 | CN101475633A Rice protein OsCSP1, encoding gene thereof and use |
| 07/08/2009 | CN101475632A Recombinant Ganoderma lucidum immunoregulation protein with antineoplastic function and medicinal preparation thereof |
| 07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 07/08/2009 | CN101474398A Use of inhibitors for the treatment of disorders related to RTK hyperfunction |
| 07/08/2009 | CN100510096C Promotor for expressing gene in fungal cell |
| 07/08/2009 | CN100510095C Method for producing polypeptide in bacillocin cell |
| 07/08/2009 | CN100510087C Modular transfection system |
| 07/08/2009 | CN100510073C Tryptase inhibitor |
| 07/08/2009 | CN100510068C A soluble complex comprising a retroviral surface glycoprotein |
| 07/08/2009 | CN100510064C Novel laccase enzyme and gene encoding the enzyme |
| 07/08/2009 | CN100510060C Method of extended culture for antigen-specific cytotoxic t lymphocytes |
| 07/08/2009 | CN100510050C Method for extracting protein from single cell |
| 07/08/2009 | CN100509847C Crystalline tumor necrosis factor receptor 2 polypeptides |
| 07/08/2009 | CN100509846C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/08/2009 | CN100509845C Pokeweed antibiotic peptides, precursor peptides thereof, polynucleotide and applications |
| 07/08/2009 | CN100509844C Variants of the major allergen phl p 1 from timothy grass |